All Stories

  1. Cover Picture: Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase (Mol. Inf. 5/2020)
  2. Improvement of Saccharification and Delignification Efficiency of Trichoderma reesei Rut-C30 by Genetic Bioengineering
  3. Proteomic Atomics Reveals a Distinctive Uracil‐5‐Methyltransferase
  4. Accurate high throughput alignment via line sweep-based seed processing
  5. CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis
  6. A Novel Divergent Gene Transcription Paradigm—the Decisive, Brain-Specific, Neural |-Srgap2–Fam72a-| Master Gene Paradigm
  7. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature
  8. Establishing a Human Adrenocortical Carcinoma (ACC)-Specific Gene Mutation Signature
  9. Brain plasticity, cognitive functions and neural stem cells: a pivotal role for the brain-specific neural master gene |-SRGAP2–FAM72-|
  10. Functional repertoire of interleukin-6 in the central nervous system – a review
  11. A novel specialized single-linkage clustering algorithm for taxonomically ordered data
  12. Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation
  13. Cognitive Functions: Human vs. Animal – 4:1 Advantage |-FAM72–SRGAP2-|
  14. Livebearing or egg-laying mammals: 27 decisive nucleotides of FAM168
  15. Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
  16. Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer
  17. All-or-(N)One – an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci
  18. Characterization of a solvent, surfactant and temperature-tolerant laccase from Pleurotus sp. MAK-II and its dye decolorizing property
  19. Characterization of a Solvent-Tolerant Manganese Peroxidase (MnP) fromGanoderma Lucidumand Its Application in Fruit Juice Clarification
  20. 3D Structure, Dimerization Modeling, and Lead Discovery by Ligand-protein Interaction Analysis of p60 Transcription Regulator Protein (p60TRP)
  21. Characterization of a novel endoglucanase fromGanoderma lucidum
  22. Ageing, dementia and society – an epistemological perspective
  23. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
  24. Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
  25. Mechanism Study of Traditional Medicine Using Proteomics Alone or Integrated with Other Systems Biology Technologies
  26. Characterization of Lignocellulolytic Enzymes from White-Rot Fungi
  27. Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17)
  28. Oxygen distribution in proteins defines functional significance of the genome and proteome of the malaria parasite Plasmodium falciparum 3D7
  29. Thymine distribution in genes provides novel insight into the functional significance of the proteome of the malaria parasite Plasmodium falciparum 3D7
  30. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology
  31. Brain site-specific proteome changes in aging-related dementia
  32. The protein p17 signaling pathways in cancer
  33. Establishing an in vivo p48ZnF bioluminescence mouse brain imaging model
  34. G Proteins, p60TRP, and Neurodegenerative Diseases
  35. Brain-Site-Specific Proteome Changes Induced by Neuronal P60TRP Expression
  36. Characterization of optimized production, purification and application of laccase from Ganoderma lucidum
  37. Secretome analysis of Ganoderma lucidum cultivated in sugarcane bagasse
  38. Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain
  40. Characterizing the neurite outgrowth inhibitory effect of Mani
  41. Tianma Modulates Blood Vessel Tonicity
  42. Tianma modulates proteins with various neuro-regenerative modalities in differentiated human neuronal SH-SY5Y cells
  43. New insights into the brain protein metabolism of Gastrodia elata-treated rats by quantitative proteomics
  44. Neuronal p60TRP expression modulates cardiac capacity
  45. Phenotyping of Tianma-Stimulated Differentiated Rat Neuronal B104 Cells by Quantitative Proteomics
  46. Quantitative Neuroproteomics of an In Vivo Rodent Model of Focal Cerebral Ischemia/Reperfusion Injury Reveals a Temporal Regulation of Novel Pathophysiological Molecular Markers
  47. P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis
  48. The novel protein MANI modulates neurogenesis and neurite-cone growth
  49. Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice
  50. Characterizing the novel protein p33MONOX
  51. Neurotrophin-4 (Ntf4) Mediates Neurogenesis in Mouse Embryonic Neural Stem Cells Through the Inhibition of the Signal Transducer and Activator of Transcription-3 (Stat3) and the Modulation of the Activity of Protein Kinase B
  52. Cardiovascular Dementia - A Different Perspective
  53. Phenotyping of an in Vitro Model of Ischemic Penumbra by iTRAQ-Based Shotgun Quantitative Proteomics
  54. Ligand-Dependent Activation of the Chimeric Tumor Necrosis Factor Receptor-Amyloid Precursor Protein (APP) Reveals Increased APP Processing and Suppressed Neuronal Differentiation
  55. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17
  56. Brain-Derived Neurotrophic Factor (BDNF) has Proliferative Effects on Neural Stem Cells through the Truncated TRK-B Receptor, MAP Kinase, AKT, and STAT-3 Signaling Pathways
  57. Interleukin-6 and Neural Stem Cells: More Than Gliogenesis
  58. Neurotrophins - More than Neurotrophic
  59. Death effector domain DEDa, a self-cleaved product of caspase-8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase-8 expression via a p53-dependent mechanism
  60. ABC transporters, neural stem cells and neurogenesis – a different perspective
  61. Brain site-specific gene expression analysis in Alzheimer's disease patients
  62. The Bad Guy Cooperates with Good Cop p53: Bad Is Transcriptionally Up-Regulated by p53 and Forms a Bad/p53 Complex at the Mitochondria To Induce Apoptosis
  63. Livin promotes Smac/DIABLO degradation by ubiquitin–proteasome pathway
  64. Alzheimers Disease - An Interactive Perspective
  65. Cytokines and Neurotrophins Interact in Normal and Diseased States
  66. Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease
  67. Nerve growth factor(NGF) induces mRNA expression of the new transcription factor protein p48ZnF
  68. Identification of rTid-1, the rat homologue of the drosophila tumor suppressor l(2)tid gene
  69. The Splicing Regulatory Protein p18SRP Is Down-Regulated in Alzheimer's Disease Brain
  70. The possible mechanisms of Aβ(1-40)- or Aβ(1-42)-induced cell death and their rescue factors
  71. Characterizing the new transcription regulator protein p60TRP
  72. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells
  73. Comparative gene identification-94—a pivotal regulator of apoptosis
  74. Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells
  75. Characterizing the signaling pathway of rat p18 amyloid beta (A??) responsive protein (p18A??rP).
  76. The 3′ untranslated region of the new rat synaptic vesicle protein 2B mRNA transcript inhibits translational efficiency
  77. Characterizing CGI-94 (comparative gene identification-94) which is down-regulated in the hippocampus of early stage Alzheimer's disease brain
  78. Identification of a New Synaptic Vesicle Protein 2B mRNA Transcript Which Is Up-Regulated in Neurons by Amyloid β Peptide Fragment (1–42)
  79. Signals regulating neurotrophin expression in glial cells
  80. Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2
  81. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression
  82. Induction of rat l-phosphoserine phosphatase by amyloid-β (1–42) is inhibited by interleukin-11
  83. Region-Specific Neurotrophin Imbalances in Alzheimer Disease
  84. Increased CSF levels of nerve growth factor in patients with Alzheimer's disease
  85. GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats
  86. Alterations in neurotrophins and neurotrophin receptors in Alzheimer’s disease
  87. Modulation of mRNA expression of the neurotrophins of the nerve-growth-factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment. II. Effects on p75 and trk receptor expression
  88. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression
  89. NF-?B modulates lipopolysaccharide-induced microglial nerve growth factor expression
  90. Modulation of mRNA expression of the neurotrophins of the nerve growth factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment
  91. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease
  92. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients
  93. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors